Low-Dose Total Skin Electron Beam Therapy Combined With Mogamulizumab for Refractory Mycosis Fungoides and Sézary Syndrome

Low-Dose Total Skin Electron Beam Therapy Combined With Mogamulizumab for Refractory Mycosis Fungoides and Sézary Syndrome

Purpose: Management of patients with refractory mycosis fungoides and Sézary syndrome (SS) is often challenging, as available therapies lack durable response and consistent activity across disease compartments. Combining low-dose total skin electron beam therapy (LD-TSEBT) upfront with mogamulizumab...

Full description

Bibliographic Details
Main Authors: Sophia Fong, BS, Eric K. Hong, BS, Michael S. Khodadoust, MD, PhD, Shufeng Li, MS, Richard T. Hoppe, MD, Youn H. Kim, MD, Susan M. Hiniker, MD
Format: Article
Language:English
Published: Elsevier 2021-05-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109420303596

Internet

http://www.sciencedirect.com/science/article/pii/S2452109420303596

Similar Items